These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6026787)

  • 1. Changes in serum potassium levels occurring in patients treated with triamterene and a triamterene-hydrochlorothiazide combination.
    Hansen KB; Bender AD
    Clin Pharmacol Ther; 1967; 8(3):392-9. PubMed ID: 6026787
    [No Abstract]   [Full Text] [Related]  

  • 2. The PACT study: post-marketing surveillance in 47,465 patients treated with Maxzide (triamterene/hydrochlorothiazide). An interim report.
    Hollenberg NK; Bannon JA
    Am J Med; 1986 Apr; 80(4A):30-6. PubMed ID: 3518430
    [No Abstract]   [Full Text] [Related]  

  • 3. Triamterene nephrolithiasis.
    Dooley DP; Callsen ME; Geiling JA
    Mil Med; 1989 Mar; 154(3):126-7. PubMed ID: 2496337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potassium restoration in hypertensive patients made hypokalemic by hydrochlorothiazide.
    Schnaper HW; Freis ED; Friedman RG; Garland WT; Hall WD; Hollifield J; Jain AK; Jenkins P; Marks A; McMahon FG
    Arch Intern Med; 1989 Dec; 149(12):2677-81. PubMed ID: 2596940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperkalemia in diabetes mellitus. Effect of a triamterene-hydrochlorothiazide combination.
    Hollenberg NK; Mickiewicz C
    Arch Intern Med; 1989 Jun; 149(6):1327-30. PubMed ID: 2730251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe Acquired Hypokalemic Paralysis in a Bodybuilder After Self-Medication With Triamterene/Hydrochlorothiazide.
    Pfisterer N; Stöllberger C; Finsterer J
    Clin J Sport Med; 2020 Sep; 30(5):e172-e174. PubMed ID: 31770156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Letter: Dyazide and hyperkalemia.
    Petersen AG
    Ann Intern Med; 1976 May; 84(5):612-3. PubMed ID: 1275375
    [No Abstract]   [Full Text] [Related]  

  • 8. Hypokalemia during the treatment of arterial hypertension with diuretics.
    Lemieux G; Beauchemin M; Vinay P; Gougoux A
    Can Med Assoc J; 1980 Apr; 122(8):905-7. PubMed ID: 7370875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diuretic induced hypokalemia in the elderly.
    Navarro RP; O'Brien DK; Nuffort P; Spencer DL
    J Fam Pract; 1982 Apr; 14(4):685-9. PubMed ID: 7069387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of a diuretic combination of triamterene and hydrochlorothiazide in elderly patients.
    Bender AD; Carter CL; Hansen KB
    J Am Geriatr Soc; 1967 Feb; 15(2):166-73. PubMed ID: 5334664
    [No Abstract]   [Full Text] [Related]  

  • 11. Incidence of cardiac arrhythmias associated with mild hypokalemia induced by low-dose diuretic therapy for hypertension.
    Peters RW; Hamilton J; Hamilton BP
    South Med J; 1989 Aug; 82(8):966-9, 976. PubMed ID: 2669155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperkalemic effects of triamterene.
    Cohen AB
    Ann Intern Med; 1966 Sep; 65(3):521-7. PubMed ID: 5911746
    [No Abstract]   [Full Text] [Related]  

  • 13. Early changes in plasma and urinary potassium in diuretic-treated patients with systemic hypertension.
    Papademetriou V; Price M; Johnson E; Smith M; Freis ED
    Am J Cardiol; 1984 Nov; 54(8):1015-9. PubMed ID: 6496322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperkalemia after triamterene in diabetic patients.
    Walker BR; Capuzzi DM; Alexander F; Familiar RG; Hoppe RC
    Clin Pharmacol Ther; 1972; 13(5):643-51. PubMed ID: 5053809
    [No Abstract]   [Full Text] [Related]  

  • 15. Blood pressure lowering and potassium conservation by triamterene-hydrochlorothiazide and amiloride-hydrochlorothiazide in hypertension.
    Maxwell MH; Brachfeld J; Itskovitz H; Lunn JA; Moser M; Zawada ET
    Clin Pharmacol Ther; 1985 Jan; 37(1):61-5. PubMed ID: 3880686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potassium-sparing effects of triamterene in the treatment of hypertension.
    Spiekerman RE; Berge KG; Thurber DL; Gedge SW; McGuckin WF
    Circulation; 1966 Sep; 34(3):524-31. PubMed ID: 5332122
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of mild-to-moderate hypertension: comparison between a calcium-channel blocker and a potassium-sparing diuretic.
    Boulet AP; Chockalingam A; Fodor JG; Laplante L; Houde M; Lenis J; Logan AG; Robitaille MN; Ryan D; Spénard J
    J Cardiovasc Pharmacol; 1991; 18 Suppl 9():S45-50. PubMed ID: 1725543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postmarketing surveillance in 70,898 patients treated with a triamterene/hydrochlorothiazide combination (Maxzide).
    Hollenberg NK; Mickiewicz CW
    Am J Cardiol; 1989 Jan; 63(4):37B-41B. PubMed ID: 2911994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subacute cutaneous lupus erythematosus-like drug eruption due to combination diuretic hydrochlorothiazide and triamterene.
    Darken M; McBurney EI
    J Am Acad Dermatol; 1988 Jan; 18(1 Pt 1):38-42. PubMed ID: 3346407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyponatraemia induced by a combination of hydrochlorothiazide and triamterene.
    Roberts CJ; Channer KS; Bungay D
    Br Med J (Clin Res Ed); 1984 Jun; 288(6435):1962. PubMed ID: 6428623
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.